학술논문

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
Document Type
article
Source
Science Immunology. 3(26)
Subject
Vaccine Related
Immunization
Vaccine Related (AIDS)
Prevention
Biotechnology
Infectious Diseases
HIV/AIDS
Inflammatory and immune system
Good Health and Well Being
Animals
Antibodies
Neutralizing
Antigens
Viral
Cell Line
Complement System Proteins
Female
Glycosylation
HIV Antibodies
Immunity
Humoral
Immunoglobulin Fc Fragments
Immunoglobulin G
Mice
Inbred BALB C
Mice
Inbred C57BL
Receptors
Fc
Language
Abstract
HIV-specific broadly neutralizing antibodies (bNAbs) confer protection after passive immunization, but the immunological mechanisms that drive their development are poorly understood. Structural features of bNAbs indicate that they originate from extensive germinal center (GC) selection, which relies on persistent GC activity. However, why a fraction of infected individuals are able to successfully drive more effective affinity maturation is unclear. Delivery of antigens in the form of antibody-immune complexes (ICs), which bind to complement receptors (CRs) or Fc receptors (FcRs) on follicular dendritic cells, represents an effective mechanism for antigen delivery to the GC. We sought to define whether IC-FcR or CR interactions differ among individuals who develop bNAb responses to HIV. Enhanced Fc effector functions and FcR/CR interactions, via altered Fc glycosylation profiles, were observed among individuals with neutralizing antibody responses to HIV compared with those without neutralizing antibody activity. Moreover, both polyclonal neutralizer ICs and monoclonal IC mimics of neutralizer antibodies induced higher antibody titers, higher-avidity antibodies, and expanded GC B cell reactions after immunization of mice via accelerated antigen deposition within B cell follicles in a complement-dependent manner. Thus, these data point to a direct role for altered Fc profile/complement interactions in shaping the maturation of the humoral immune response, providing insights into how GC activity may be enhanced to drive affinity maturation in next-generation vaccine approaches.